This document is an excerpt from the EUR-Lex website
Donations of human blood and plasma provide the basis for a wide range of essential, often life-saving, therapies. Blood and its components are also used for routine surgery to prolong a patient's life. Their quality and safety must be guaranteed to prevent any transmission of infection or disease.
EU countries must ensure that:
Lastly, blood establishments must evaluate all blood donors, test each donation (to check if a donor has hepatitis B or C, for instance) and ensure proper storage, transport and distribution of the donated blood.
It entered into force on 8 February 2003. EU countries had to incorporate it in their national law by 8 February 2005.
Blood, tissues and organs on the European Commission's website.
Directive 2002/98/EC of the European Parliament and of the Council of 27 January 2003 setting standards of quality and safety for the collection, testing, processing, storage and distribution of human blood and blood components and amending Directive 2001/83/EC (OJ L 33, 8.2.2003, pp. 30–40)
Commission Directive 2004/33/EC of 22 March 2004 implementing Directive 2002/98/EC of the European Parliament and of the Council as regards certain technical requirements for blood and blood components (OJ L 91, 30.3.2004, pp. 25–39). Successive amendments to Directive 2004/33/EC have been incorporated into the original text. This consolidated version is of documentary value only.
Commission Directive 2005/61/EC of 30 September 2005 implementing Directive 2002/98/EC of the European Parliament and of the Council as regards traceability requirements and notification of serious adverse reactions and events (OJ L 256, 1.10.2005, pp. 32–40)
Commission Directive 2005/62/EC of 30 September 2005 implementing Directive 2002/98/EC of the European Parliament and of the Council as regards Community standards and specifications relating to a quality system for blood establishments (OJ L 256, 1.10.2005, pp. 41–48)
last update 24.11.2015